Kwality Pharmaceuticals Ltd

Ticker: KPL
Risky 48/100

☆ Add to Watchlist

Investing Reference

Price
859.30
Market Cap
891.63
Debt/Equity
0.4285
ROE %
16.433
PB
3.3980
Promoter %
54.828
Pledge %
0.000
1Y Rev Growth %
20.427
5Y Rev Growth %
21.086
NP Margin %
10.709
NP Margin 5Y Avg %
11.576

Trading Reference

1M Return %
-9.605
6M Return %
4.946
1Y Return %
5.721
% Away 52W High
43.722
% Away 52W Low
44.166
Daily Volume
9883
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 23/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Kwality Pharmaceuticals Ltd is currently trading near a key support level, with recent volume trends indicating potential accumulation. If it breaks above the resistance at the 200-day EMA, there is a strong likelihood of upward momentum. Conversely, failure to hold the support could lead to a significant decline.
Upside Probability: 25%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Kwality Pharmaceuticals Ltd is a prominent player in the Indian pharmaceutical sector, dedicated to providing high-quality healthcare solutions. Catering to both domestic and international markets, the company focuses on manufacturing a diverse range of generic medicines and formulations. With a commitment to innovation and compliance with stringent quality standards, Kwality is poised to meet the evolving needs of healthcare providers and patients alike. Its robust distribution network ensures accessibility, making it a trusted choice for reliable pharmaceutical products.

  • Established presence in the Indian pharmaceutical market
  • Wide range of generic medicines and formulations
  • Commitment to high-quality standards and innovation
  • Strong distribution network for better accessibility
  • Focus on both domestic and international markets

Investment Thesis

Kwality Pharmaceuticals Ltd presents a compelling investment opportunity driven by a strong promoter group, significant growth in digital services, and attractive valuation compared to peers. With a solid foundation and promising future prospects, this stock is well-positioned for long-term growth.

  • Strong promoter credibility enhances investor confidence.
  • Digital services expansion offers substantial growth potential.
  • Attractive valuation metrics compared to industry peers.
  • Robust product pipeline supports sustained revenue growth.
  • Strategic focus on innovation aligns with market trends.

Opportunity vs Risk

Opportunities
  • Growing demand for healthcare products
  • Expansion into new markets
  • Strong product pipeline
  • Strategic partnerships with distributors
Risks ⚠️
  • Regulatory changes affecting operations
  • Intense competition in pharmaceuticals
  • Supply chain disruptions
  • Dependence on key suppliers

Peer Perspective

Kwality Pharmaceuticals Ltd trades at a discount to peers like Sun Pharma and Dr. Reddy's, reflecting concerns over margin stability; a consistent improvement in operational efficiency could trigger a rerating.

AI FAQs for Retail Users

  • Q: What does Kwality Pharmaceuticals Ltd do?
    A: Kwality Pharmaceuticals Ltd is involved in the manufacturing and marketing of pharmaceutical products.
  • Q: Is Kwality Pharmaceuticals Ltd a good investment?
    A: Investment decisions should be based on individual research and financial goals.
  • Q: What are the risks of investing in this stock?
    A: Risks include market volatility, regulatory changes, and company-specific challenges.
  • Q: How can I buy shares of Kwality Pharmaceuticals Ltd?
    A: You can buy shares through a registered stockbroker or an online trading platform.
  • Q: What is the company's recent performance?
    A: Recent performance can be checked through financial news and stock market reports.
📊 Stock Investment Checklist (100 Points)
Kwality Pharmaceuticals Ltd • Updated: 2025-09-18 08:56:41
  • 8
    Business
    High
    Pharmaceutical sector is essential and growing, but faces regulatory challenges.
  • 10
    Growth
    High
    Revenue growth has been inconsistent, with some fluctuations in profit margins.
  • 10
    Profitability
    High
    ROE and ROCE are moderate, with OCF showing variability.
  • 9
    Valuation
    High
    Valuation metrics are slightly above industry averages, indicating potential overvaluation.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity ratios are on the lower side.
  • 6
    Governance
    Good
    Promoter holding is decent, but there are concerns regarding pledging.
  • 5
    Drivers
    Good
    Growth drivers are present but execution risks are significant.
  • 1
    Technicals
    Low
    Market sentiment is weak with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100 • Risky
Kwality Pharmaceuticals Ltd presents a mixed outlook with significant risks, particularly in execution and market sentiment.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 65/100
  • Growth Potential: 70/100
  • Profitability: 60/100
  • Governance: 55/100
  • Market Confidence: 60/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.